PharmX Technologies (ASX:PHX) EBIT per Share : A$0.00 (TTM As of Dec. 2023)

View and export this data going back to 1973. Start your Free Trial

What is PharmX Technologies EBIT per Share?

PharmX Technologies's EBIT per Share for the six months ended in Dec. 2023 was A$0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00.

During the past 3 years, the average EBIT per Share Growth Rate was 20.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for PharmX Technologies's EBIT per Share or its related term are showing as below:

ASX:PHX' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -43.3 Med: 15.2 Max: 50.9
Current: 20.6

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of PharmX Technologies was 50.90% per year. The lowest was -43.30% per year. And the median was 15.20% per year.

ASX:PHX's 3-Year EBIT Growth Rate is ranked better than
64.05% of 509 companies
in the Healthcare Providers & Services industry
Industry Median: 8.6 vs ASX:PHX: 20.60

PharmX Technologies's EBIT for the six months ended in Dec. 2023 was A$0.44 Mil.

PharmX Technologies EBIT per Share Historical Data

The historical data trend for PharmX Technologies's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmX Technologies EBIT per Share Chart

PharmX Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EBIT per Share

Get a 7-Day Free Trial

PharmX Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial															-	-	-	-	-

PharmX Technologies EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

PharmX Technologies's EBIT per Share for the fiscal year that ended in Jun. 2023 is calculated as

	EBIT per Share		(A: Jun. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.665	/	597.169
=	-0.00

PharmX Technologies's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.436	/	597.853
=	0.00

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00

PharmX Technologies (ASX:PHX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

PharmX Technologies EBIT per Share Related Terms

Thank you for viewing the detailed overview of PharmX Technologies's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmX Technologies (ASX:PHX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PharmX Technologies Ltd (ASX:PHX) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Castlereagh Street, Level 11, Sydney, NSW, AUS, 2000

Website

https://www.corumgroup.com.au

PharmX Technologies Ltd Formerly Corum Group Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business. the company discontinued the e-commerce business in 2022.